Correlation Between Decibel Cannabis and Medipharm Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Decibel Cannabis and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Decibel Cannabis and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Decibel Cannabis and Medipharm Labs Corp, you can compare the effects of market volatilities on Decibel Cannabis and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Decibel Cannabis with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Decibel Cannabis and Medipharm Labs.

Diversification Opportunities for Decibel Cannabis and Medipharm Labs

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Decibel and Medipharm is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Decibel Cannabis and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Decibel Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Decibel Cannabis are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Decibel Cannabis i.e., Decibel Cannabis and Medipharm Labs go up and down completely randomly.

Pair Corralation between Decibel Cannabis and Medipharm Labs

Assuming the 90 days horizon Decibel Cannabis is expected to generate 1.43 times more return on investment than Medipharm Labs. However, Decibel Cannabis is 1.43 times more volatile than Medipharm Labs Corp. It trades about 0.02 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about 0.01 per unit of risk. If you would invest  6.83  in Decibel Cannabis on August 29, 2024 and sell it today you would lose (2.33) from holding Decibel Cannabis or give up 34.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Decibel Cannabis  vs.  Medipharm Labs Corp

 Performance 
       Timeline  
Decibel Cannabis 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Decibel Cannabis are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, Decibel Cannabis reported solid returns over the last few months and may actually be approaching a breakup point.
Medipharm Labs Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward indicators, Medipharm Labs is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Decibel Cannabis and Medipharm Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Decibel Cannabis and Medipharm Labs

The main advantage of trading using opposite Decibel Cannabis and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Decibel Cannabis position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.
The idea behind Decibel Cannabis and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated